Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xeris Biopharma Holdings (XERS) Depreciation & Amortization (CF) (2020 - 2025)

Xeris Biopharma Holdings filings provide 6 years of Depreciation & Amortization (CF) readings, the most recent being $335000.0 for Q4 2025.

  • On a quarterly basis, Depreciation & Amortization (CF) rose 7.03% to $335000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $1.3 million, a 7.01% increase, with the full-year FY2025 number at $1.3 million, up 7.01% from a year prior.
  • Depreciation & Amortization (CF) hit $335000.0 in Q4 2025 for Xeris Biopharma Holdings, down from $338000.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $391000.0 in Q3 2023 to a low of $281000.0 in Q2 2024.
  • Median Depreciation & Amortization (CF) over the past 5 years was $336000.0 (2021), compared with a mean of $337750.0.
  • Biggest five-year swings in Depreciation & Amortization (CF): decreased 27.2% in 2024 and later grew 15.66% in 2025.
  • Xeris Biopharma Holdings' Depreciation & Amortization (CF) stood at $349000.0 in 2021, then increased by 4.87% to $366000.0 in 2022, then fell by 5.46% to $346000.0 in 2023, then decreased by 9.54% to $313000.0 in 2024, then increased by 7.03% to $335000.0 in 2025.
  • The last three reported values for Depreciation & Amortization (CF) were $335000.0 (Q4 2025), $338000.0 (Q3 2025), and $325000.0 (Q2 2025) per Business Quant data.